Areas of Focus
- Development of novel RNA vaccine technology
- RNA tumor immunotherapy
- Development of novel gene editing technology
Work Experience
- 2020.07 – 2022.11 - Peking University - Postdoctoral Researcher
- 2022.11 – Present - Fudan University - Junior Researcher, Doctoral Supervisor, Principal Investigator
Academic Background & Achievements
- 2011.09 – 2015.07 Bachelor's Degree in Biotechnology (Immunology Engineering): Soochow University
- 2015.09 – 2020.07 Ph.D. in Biochemistry and Molecular Biology: Peking University
Publications
- Circular RNA vaccines against SARS-CoV-2 and emerging variants., Liang Qu*, Zongyi Yi*, Yong Shen*, Liangru Lin, Feng Chen, Yiyuan Xu, Zeguang Wu, Huixian Tang, Xiaoxue Zhang, Feng Tian, Chunhui Wang, Xia Xiao, Xiaojing Dong, Li Guo, Shuaiyao Lu, Chengyun Yang, Cong Tang, Yun Yang, Wenhai Yu, Junbin Wang, Yanan Zhou, Qing Huang, Ayijiang Yisimayi, Shuo Liu, Weijin Huang, Yunlong Cao, Youchun Wang, Zhuo Zhou, Xiaozhong Peng, Jianwei Wang, Xiaoliang Sunney Xie, Wensheng Wei#., 2022
- Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs., Liang Qu*, Zongyi Yi*, Shiyou Zhu*, Chunhui Wang*, Zhongzheng Cao*, Zhuo Zhou*, Pengfei Yuan*, Ying Yu, Feng Tian, Zhiheng Liu, Ying Bao, Yanxia Zhao, Wensheng Wei#., 2019
- Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo., Zongyi Yi*, Liang Qu*, Huixian Tang*, Zhiheng Liu, Ying Liu, Feng Tian, Chunhui Wang, Xiaoxue Zhang, Ziqi Feng, Ying Yu, Pengfei Yuan, Zexuan Yi, Yanxia Zhao, Wensheng Wei#., 2022
- Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication., Chunsheng Dong*#, Liang Qu*, Haoyi Wang, Lin Wei, Yuanshu Dong, Sidong Xiong#., 2015
Awards
- 2020 - Outstanding Doctoral Dissertation, Peking University
- 2020 - Wu Rui Award, Wu Rui Memorial Foundation